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 1. INTRODUCTION 
 
1.1 COP1, the Constitutive Photomorphogenic Protein 1 
 
1.1.1. Definition  
UVB light, one of the most important physical carcinogens in the environment, has 
been shown to trigger a broad range of changes in gene expression in plants and in non-plant 
multicellular organisms. Many components of the light signaling cascades have been revealed 
over the years, mostly by genetic approaches. Among them, COP1 (constitutive 
photomorphogenic protein 1) was one of the first cloned and is one of the most extensively 
studied. COP1 is a RING-finger protein; it was first described in Arabidopsis thaliana.  
 
 
1.1.2. COP1 in plants 
It has been established that Arabidopsis thaliana COP1 (AtCOP1) functions as an 
essential negative regulator of light-mediated plant development, as an E3 ubiquitin ligase, is 
essential for the proteasome-dependant degradation of a number of bZIP-type transcription 
factors, such as HY5, HYH, LAF1 and HFR1. Genome-wide microarray analysis has 
demonstrated that AtCOP1 regulates most of the light-responsive genes under various light 
conditions. AtCOP1 functions as a crucial developmental switch through targeting key 
transcription factors for degradation, thereby controlling light-responsive gene expression and 
photomorphogenic development. In photosynthetizing cells, the subcellular distribution of 
AtCOP1 is adjusted according to the light conditions.  
 
 
1.1.3. COP1 in non-plant organisms 
Although, COP1 also exists in non-plant multicellular organisms, its function is less 
understood among vertebrates, COP1 is well conserved among fish, amphibians, birds and 
mammals, it is apparent that, unlike plants, animals do not undergo photomorphogenesis. 
Several initial studies have implied that animal COP1 may have adopted roles in 
tumorigenesis and stress response, although its biochemical activities and some of the 
signaling elements it interacts with appear to be conserved between plants and animals. 
 
 
1.1.4. Structural and functional analogy between AtCOP1 and mammalian COP1 
Mammalian COP1 (MmCOP1), as human COP1 (huCOP1), is located at the 
chromosome 1 and exhibits a high degree of sequence conservation and domain organization 
with AtCOP1, suggesting the possibility of functional conservation. Both MmCOP1 and 
AtCOP1 contain three conserved structural domains: a RING finger at the amino terminus, a 
coiled-coil domain in the middle, and a carboxyl-terminal WD40 repeat domain. Earlier 
studies suggested that COP1 acts primarily as a homodimer, and probably dimerizes through 
the coiled-coil domain. The coiled-coil region and the seven WD40 motifs region comprise 
potential interaction domains for other protein partners.  
As compared with AtCOP1, MmCOP1 has an N-terminal extension that may be 
responsible for targeting COP1 to the nuclear envelope (NE) part of the nucleus. COP1 is 
predominantly localized in the nucleus, but a small amount may also be present in the cytosol. 
COP1 shuttles between the nucleus and the cytoplasm and forms subnuclear speckles in both 
plants and mammals.  
 
1.2. Function of mammalian COP1 
MmCOP1, like AtCOP1, is involved in ubiquitination and is itself a substrate of its 
own ubiquitination activity. COP1 ubiquitination substrates have been identified in mammals: 
c-Jun and p53. COP1-mediated p53 degradation is an important regulatory mechanism for the 
p53 function in the cell: depletion of COP1 leads to p53 accumulation and cell-cycle arrest, 
while the overexpression of COP1 inhibits p53-dependent apoptosis. Overexpression of 
huCOP1 in mammalian cells downregulates c-Jun-dependent transcription and expression of 
the AP-1 target genes.  
 
1.3. p53 regulation in keratinocytes and in the epidermis 
p53, a nuclear phosphoprotein first identified by Lane and Crawford in 1979, activates 
the transcription of many genes involved in cell differentiation, proliferation, induction of 
DNA repair pathways and cell death. The loss of p53 function increases the risk of 
development for certain types of cancers. As regards UV-induced skin tumors, p53 is 
considered to play an important role in their pathogenesis.  
In normal unstressed cells, p53 is a very unstable protein with a half-life ranging from 
5 to 30 min. Its short half-life is linked to polyubiquitination and proteasome-dependent 
degradation, while the protein is regulated through posttranslational modifications including 
phosphorylation and acetylation. The p53 protein level is increased and stabilized in both 
murine and human keratinocytes when treated with UVB light. p53 accumulates 
intracellularly up to readily detectable levels, arresting cells in the G1 phase, until cellular 
damage is fully repaired or the cell-death pathway is initiated.  
In normal human skin, p53 is generally not detected in the epidermis, which has been 
attributed to its relatively short half-life. p53 is the key UV-responsive gene in skin, whose 
mutation is thought to initiate carcinogenesis, but its role in the control of keratinocyte 
proliferation and differentiation is less clear.  
 
1.4. E3 ubiquitin ligases and p53 regulation 
p53 expression has been shown to be controlled by a plethora of upstream regulatory 
proteins, the main antagonists of p53 are Mdm2, Pirh2 and huCOP1 E3 ubiquitin ligases. 
These proteins directly promote p53 ubiquitination and its proteasome-dependent degradation. 
Mdm2 interacts physically with and ubiquitinates p53, leading to its degradation in the 
cytosolic 26S proteasome, but it has also been demonstrated that p53 degradation may occur 
in either the cytosolic or the nuclear proteasomes and does not require nuclear export. In 
addition to Mdm2, Pirh2 and COP1 have been shown to impart specificity toward p53. The 
nuclear monoubiquitination of p53 by Mdm2 leads to the accumulation of p53. Following 
monoubiquitination, p53 is polyubiquitinated by Mdm2, Pirh2, COP1 or a complex of these 
proteins, and degraded by cytosolic 26S proteasomes. It has been demonstrated that COP1 
promotes p53 turnover independently of Mdm2 or Pirh2 in U2OS osteosarcoma cells.  
 
1.5. Kinetics of p53 expression during keratinocyte differentiation 
Keratinocytes undergo a complex developmental program as they progress from the 
basal to the spinous, granular and finally the cornified layer of the epidermis. p53 is expressed 
at low levels in UV-unexposed skin and is activated during the exit from the proliferative 
state, resulting in inhibition of cell division and stimulation of differentiation. Later, as the 
keratinocytes progress in the differentiation associated the cell death program, they become 
insensitive to p53-induced apoptosis. UV light induces p53 in the proliferative compartment 
of the basal layer cells, resulting in cell cycle arrest and apoptosis, which protects from cancer 
induction. When p53 is inhibited in the basal layer by a negative regulator protein, such as 
Mdm2, this leads to decreased differentiation and increased proliferation.  
1.6. Effects of genotoxic stress on E3 ubiquitin ligases 
In wild-type p53 expressing cells, E3 ubiquitin ligases, such as Mdm2, Pirh2 and 
COP1, are induced following genotoxic stress, caused, for example, by ionizing radiation (IR) 
or UV irradiation. Mdm2 expression increases in a p53-dependent manner following IR, and 
its regulation after UVB irradiation in human keratinocytes is also well elucidated. Pirh2 
expression is not enhanced following IR or UV treatment in wild-type p53-expressing cell 
lines, but it has not been investigated in human keratinocytes. COP1 protein expression 
increases following treatment with IR in wild-type p53 expressing cells, UVC results in 
biphasic mRNA changes and an elevated COP1 protein level in U2OS osteosarcoma cells and 
HeLa cells.  
 
1.7. COP1 in human tumors 
 As COP1 is a critical negative regulator of p53 in normal and cancer cell lines, its role 
has been investigated in detail in human cancers . The overexpression of COP1 was detected 
predominantly, but not exclusively, in wild-type p53-containing cancers, such as ovarian 
tumors, breast adenocarcinomas and hepatocellular carcinomas, indicating that one of the 
major roles of COP1 is to repress p53-dependent tumor suppression. Finally, COP1 may 
function as an oncogene and promote tumorigenesis, especially in tumors in which p53 is not 
mutated. Investigation of COP1 and the p53-associated functional network in hepatocellular 
carcinomas resulted in the development of new targeted therapeutics which use revealed that 
the antiproliferative effects of COP1 blockade suppressed neoplastic growth in both wild-type 
and mutant p53-containing liver tumors, without unwanted immune responses. 
 
 
2. AIMS 
 
In human keratinocytes, the role of huCOP1 protein has not yet been characterized, therefore 
we aimed  
• to characterize huCOP1 is expression in cultured human keratinocytes and in 
human epidermis, 
• to investigate the effect of UVB on huCOP1 expression in human cultured 
keratinocytes and human epidermis, 
• to elucidate the COP1-p53 interaction in human keratinocytes,  
• to determine the effect of UVB in COP1-silenced human keratinocytes 
• to characterize changes in COP1 expression during keratinocyte 
differentiation. 
 
 
3. MATERIALS AND METHODS 
 
3.1. Human tissue samplas. Culturing of normal human keratinocytes and HaCaT 
keratinocytes 
Human tissue samples from various human organs were taken from patients who 
underwent different operations at the Department of Surgery, University of Szeged. Only non-
involved, healthy tissues were used for RNA isolation.  All tissue samples were taken with the 
patients’ informed consent and the approval of the local committee 
Skin biopsies were obtained from healthy individuals undergoing plastic surgery; 
institutional approval and patient consent was given for experiments in adherence to the 
Helsinki guidelines. After removal of the subcutaneous tissue, skin biopsies were incubated 
overnight at 4 °C in Dispase solution (Roche). The epidermis was separated from the dermis, 
and epidermal cells were prepared by using trypsin (0.25%). Human epidermal keratinocytes 
were seeded in serum-free Keratinocyte Basal Medium (Gibco) supplemented with L-
glutamine and antibiotic/antimycotic solution containing penicillin, streptomycin and 
amphotericin B (Sigma). Keratinocytes were grown at 37 oC in a 5% CO2 atmosphere. 
For the differentiation of keratinocyte cultures, normal human keratinocytes were 
cultured until 90-95% confluence in the third passage. The culturing conditions were altered 
by increasing the calcium concentration in the culture media to 1.7 mM (in the form of 
CaCl2). Samples were taken at 0, 1, 2, 4, 6, 8 and 10 days after switching to the high calcium 
concentration medium.  
The spontaneously immortalized human keratinocyte cell line, HaCaT, kindly 
provided by Dr. N. E. Fusening (Heidelberg, Germany), was maintained in high-glucose 
DMEM (Gibco), with 10% fetal bovine serum (HyClone), supplemented with L-glutamine 
and antibiotic/antimycotic solution containing 100 U/l penicillin, 100 µl/ml streptomycin and 
amphotericin B (Sigma), at 37 °C in a 5% CO2 atmosphere. 
 
3.2. Immunocytochemistry, immunohistochemistry and immunofluorescence staining 
Immunocytochemistry: Keratinocytes were grown on culture slides (BD Falcon). The 
slides were fixed and incubated with the primary rabbit anti-COP1 antibody (Bethyl), at a 
dilution of 1:5000; control slides were incubated with a mixture of COP1 Blocking peptide 
(Bethyl) and rabbit anti-COP1 antibody in a ratio of 3:1. After a rinse in TBS-Triton-X, 
sections were incubated with Alexa Fluor 488 labelled secondary anti-rabbit antibody 
(Invitrogen) (dilution 1:800) for 3 hs, and were then stained with DAPI to detect the nuclei. 
For detection and analysis, Tissue Facs (Tissue Gnostics) and an FV 1000 confocal 
microscope (Olympus) were used.  
Immunohistochemical staining: Formalin-fixed, paraffin-embedded skin tissue 
sections were dewaxed. Nonspecific staining was prevented by preincubation, and the slides 
were then incubated overnight at 4 °C in a humid chamber with the primary antibody; rabbit 
anti- COP1 antibody was applied at 1:5000 dilution, and rabbit IgG (NeoMarkers) was used 
for isotype control staining. Slides were then incubated with a biotinylated secondary 
antibody (anti-rabbit IgG) at 1:800 dilution for 1 h at room temperature, followed by 
incubation with horse radish peroxidase-conjugated streptavidin for 1 h at room temperature 
(both from Vectastain ABC Kit), and at the end of the staining procedure peroxidase activity 
was detected by using 3,3-amino-9 ethylcarbazole (Sigma) as substrate. Slides were 
counterstained with hematoxylin (Sigma). Tissue staining was visualized with a Zeiss Axio 
Imager microscope and photographed with a PixeLINK digital camera. 
 Immunofluorescence staining: was performed as described above in connection with 
the immunohistochemical staining until the incubation with the primary antibody. The slides 
were then incubated at 4 °C overnight in a humid chamber with the primary antibody; rabbit 
anti-COP1 antibody was applied at 1:4000 dilution; control slides were incubated with a 
mixture of COP1 Blocking peptide and rabbit anti-COP1 antibody in a ratio of 3:1. After that, 
sections were incubated with Alexa Fluor 488-labeled secondary anti-rabbit antibody (dilution 
1:500) for 3 hs, and were then stained with DAPI to detect the nuclei. For detection and 
analysis, Tissue Facs (Tissue Gnostics) were used 
 
3.3. Constructs 
The pSUPER vector system (Oligoengine) was used for the transient expression of 
short interfering RNAs (siRNAs). Fifty-three-nt-long oligonucleotides of COP1 
5’AGCTTcttgatttggccaatgtcaTTCAAGAGAtgacattggccaaatcaagttC3’ (sense) and COP1 
5’AgaactaaaccggttacagtAAGTTCTCTactgtaaccggtttagttcaaGAGCT3’ (antisense) were 
cloned into the pSuperior.puro vector downstream of the H1 promoter.  
3.4. Nucleofection 
For silencing the expression of the COP1 gene, 7-8 x 105 cells were transiently 
transfected with a COP1 siRNA producing construct (siCOP1), and another group of cells 
received the empty pSUPER vector (Sp). DNA for transfection was purified with the Qiagen 
Plasmid Mini Kit (Qiagen). Transfection was carried out by nucleofection (Amaxa), and the 
Human Keratinocyte Kit (VPD-1002; Amaxa) was used for the nucleofection of 
keratinocytes. The transfection efficacy was determined by analyzing the expression of green 
fluorescent protein (GFP) with a FACScalibur flow cytometer and CellQuest software 
(Becton Dickinson) and the mean fluorescence intensity of the expressing construct was 
measured. The average efficacy of transfection was ~60 %. 
 
3.5. UVB irradiation (FS20 lamp, excimer laser) 
An FS20 lamp (Westinghouse) was used as a radiation source for UVB. To determine 
the highest nonlethal dose of UVB, we irradiated keratinocytes with 0, 10, 20, 40 and 60 
mJ/cm2 UVB light, and the viability of the treated cells was analyzed by MTT assay 24 and 
48 hs after irradiation. The 40 mJ/cm2 found to be the highest nonlethal UVB dose was 
therefore used in subsequent experiments. Samples for mRNA expression experiments were 
collected 12 hs after irradiation, while samples for protein expression experiments were 
collected 24 hs after irradiation. 
The 308 nm excimer laser was utilized for human skin irradiation. The minimal 
erythema dose (MED) was determined with increasing doses of 308 nm UVB, and 2 MED 
was used for irradiation on a non-sun-exposed area of the body in subsequent experiments. 
Skin biopsies (6 mm) were taken from irradiated and non-irradiated skin 24 and 48 hs after 
irradiation with the patients’s informed consent.  
 
3.6. Reverse transcription and real-time RT-PCR 
Total RNA was isolated from cell cultures with the TRIzol reagent (Life 
Technologies) 12 h after UVB irradiation, following the instructions of the manual. cDNA 
was generated with oligo(dT) and random hexamer primers from 1 µg of RNA, using the 
iScriptTM cDNA Synthesis Kit (Bio-Rad Laboratories) in a final volume of 20 µl. After 
reverse transcription, the real-time RT-PCR was performed to compare the abundance of 
COP1 mRNA using TaqMan® Gene Expression Assays (Applera) for the RFWD2 (cat. No. 
Hs00375437_m1) and for p53 (cat. No. Hs01034249_m1). The abundance of the gene of 
interest transcript was normalized to the expression of 18S ribosomal RNA for each examined 
sample. The primers for 18S were: 18S RNA forward: CGGCTACCACATCCAAGGAA, 
18S RNA reverse: GCTGGAATTACCGCGGCT, 18S RNA TaqMan probe: TexRed-
TGCTGGACCAGACTTGCCCTC-BHQ-1 (Integrated DNA Technologies, Coralville, IA, 
USA). The RT-PCR reactions were performed by using iQ Supermix in an iCycler (Bio-Rad).  
 
3.7. Western blot analysis 
Cells were washed twice with PBS, and protein was extracted by resuspending the 
cells in a solution containing 12.5% 0.5 mM Tris (pH 6.8), 2.5% 200 mM EDTA, 15% 10% 
SDS, 70% H2O, 10 µl of protease inhibitor and 50 µl of ß-mercaptoethanol per ml (all 
chemicals were obtained from Sigma-Aldrich) 24 h after UVB irradiation. Protein lysates 
were incubated for 5 min on ice and, after a 30-sec hard vortexing, cell debris was removed 
by centrifugation at 10 000 g for 10 min at 4 °C. For western-blot analysis, equal amounts of 
proteins were run on SDS-PAGE and then transferred to nitrocellulose membrane (Bio-Rad). 
Membranes were blocked by incubation in Tris-buffered saline (150 mM NaCl, 25 mM Tris, 
pH 7.4) containing 0.05% Tween 20 (Sigma-Aldrich) and 3% non-fat dry milk (Fluka Chemie 
AG) for 2 hs at room temperature and subsequently incubated overnight at 4 °C with purified 
mouse monoclonal anti-human p53 antibody (Calbiochem), rabbit polyclonal anti-human 
COP1 antibody (Bethyl), and rabbit monoclonal anti-actin antibody (Sigma-Aldrich). 
Alkaline phosphatase-conjugated goat anti-mouse IgG (Sigma-Aldrich) and anti-rabbit IgG 
(Sigma-Aldrich) were used as secondary antibodies at 1:2000 dilution in the blocking buffer 
and membranes were incubated for 2 hs at room temperature. The blots were developed by 
using 5-bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium as substrate (BCIP/NBT, 
Sigma-Aldrich). 
 
 
4. RESULTS 
 
4.1. COP1 expression and subcellular localization in cultured normal human 
keratinocytes and HaCaT cells  
Only limited information is available on COP1 expression in normal human tissue 
samples, and we therefore set out to determine COP1 expression in a set of RNA samples 
isolated from various human organs. We were especially interested in whether COP1 was 
expressed in the epidermis. COP1 expression was detected in all of the studied organ types. 
Interestingly, the level of expression differed to a great extent in the different organs. The 
lowest level of COP1 mRNA was detected in the breast sample, in agreement with earlier 
literature data. The highest level was seen in the gallbladder, 16-fold higher than in the breast. 
We also demonstrated by RT-PCR and western blot hybridization assays that normal 
human cultured keratinocytes express COP1 mRNA and protein. COP1 mRNA was detected 
both in normal human keratinocytes and in HaCaT keratinocytes. In HaCaT keratinocytes the 
amount of COP1 mRNA was higher. As demonstrated by western blot analysis, HaCaT cells 
also expressed higher levels of COP1 protein compared to normal human keratinocytes. To 
examine the role of COP1 as a regulator of p53 in keratinocytes, we used normal 
keratinocytes for our subsequent investigations. Since HaCaT cells express an extremely high 
and stable level of p53 protein, HaCaT cells did not seem to be a good model cell to study 
COP1-p53 interactions.  
We next determined the subcellular localization of COP1 protein in cultured normal 
human keratinocytes. COP1 protein was detected both in the cytoplasm as well as in the 
nucleus in unstressed keratinocytes compared to control cells incubating with blocking peptid 
before staining. The bulk of the immunofluorescence staining of COP1 was restricted to the 
nucleus, and only mild positivity was visible in the cytoplasm.  
 
 
4.2. COP1 and p53 expression in UVB-irradiated keratinocytes 
 
COP1 mRNA expression decreases after UVB irradiation in keratinocytes. COP1 is a 
central negative regulator of photomorphogenesis in plants. In human keratinocytes permanently 
exposed to UVB, the role of huCOP1 has not yet been characterized. For further investigation of 
huCOP1 in epidermal cells, we performed in vitro and in vivo experiments. To determine the highest 
nonlethal dose of UVB, we irradiated keratinocytes with 0, 10, 20, 40 and 60 mJ/cm2 UVB 
light. The dose-dependent changes in COP1 mRNA expression were detected and the 
viability of the irradiated cells was analyzed by MTT assay. The 40 mJ/cm2 found to be the 
highest nonlethal UVB dose, 70-80% of the treated cells in the culture survived it, therefore 
we applied this dose for the irradiation of subconfluent keratinocyte cultures.  
 To measure the kinetic changes in COP1 mRNA expression, keratinocytes were 
harvested at various time points (0, 6, 12 and 24 hs) after exposure to 40 mJ/cm2 UVB (n=3) 
and the COP1 mRNA expression was determined by real-time RT-PCR. The COP1 mRNA 
levels started to decline within 6 h after UVB exposure, were at an almost undetectable level 
after 12 hs, and then slowly increased, approaching the normal value at 24 h. 
 
UVB irradiation decreases the COP1 protein level in keratinocytes. We determined the 
abundance of COP1 and p53 proteins in keratinocytes (n=6) at various time-points (0, 6, 12 
and 24 hs) after irradiation with 40 mJ/cm2 UVB. The UVB-induced a dose-dependent 
decreases in COP1 protein are shown in Fig. 10. In contrast with COP1 mRNA, COP1 protein 
reached its minimum level at 24 h after UVB treatment. The p53 protein level was already 
increased 6 hs after UVB exposure and remained at high levels throughout the 24-h 
experimental period. 
To measure the kinetic changes in p53 mRNA expression, keratinocytes were 
harvested at various time points (0, 6, 12 and 24 hs) after exposure to 40 mJ/cm2 UVB (n=3) 
and the p53 mRNA expression was determined by real-time RT-PCR. In contrast with the 
COP1 mRNA, the p53 mRNA levels were not significantly changed during 12 hs after 
irradiation, but a marked increase was apparent at 24 h after UVB exposure. These results 
were in agreement with previously published data on the UV-induced p53 expression in 
keratinocytes. 
 
UVB irradiation alters the subcellular localization of COP1 protein in keratinocytes. 
Immunofluorescence staining of COP1 demonstrated that treatment with 40 mJ/cm2 UVB 
affects the subcellular distribution of the protein. Following UVB treatment, a substantial 
proportion of the COP1 protein was detected in the cytoplasm. This was in stark contrast with 
the untreated cells, in which COP1 was predominantly localized in the nucleus. However, in 
the cytoplasm marked perinuclear COP1 staining in the UVB-irradiated keratinocytes was 
apparent. Semiquantitative analysis of immunofluorescence staining demonstrated that 
treatment with 40 mJ/cm2 UVB affected the COP1 expression both in the nuclei and in the 
cytoplasm, to approximately the same extent.  
 
 
4.3. Up-regulated p53 protein expression is further increased by UVB irradiation in 
gene-specifically silenced COP1 cells 
Early data on COP1 expression in mammalian cells indicated that it is a critical 
negative regulator of p53 protein. UVB irradiation and COP1 silencing have an additive effect 
on the induction of p53 expression. To gain further insight into the p53 regulatory function of 
COP1 in keratinocytes, we determined p53 protein levels in cells in which the expression of 
COP1 was specifically silenced by shCOP1 RNA. Western-blot experiments revealed that the 
expression of shCOP1 RNA resulted in the depletion of COP1 protein and significant up-
regulation of p53 protein as compared with the mock-transfected cells.  
We next investigated the effect of UVB irradiation in shCOP1-transfected 
keratinocytes treated with 40 mJ/cm2. In these experiments, we monitored the intracellular 
levels of COP1 and p53 proteins 24 hs after irradiation. We demonstrated that UVB 
irradiation further decreased the level of COP1 protein, whereas the expression of p53 
exhibited an additional increase. We concluded that COP1 silencing and UVB irradiation 
have additive effects on p53 protein accumulation in normal human keratinocytes.  
 
 
4.4. COP1 expression in normal and UVB-irradiated human skin 
COP1 protein expression was detected in normal human skin with 
immunohistochemistry. COP1 expression was the most prevalent in the stratum granulosum 
of the epidermis, and mild positivity was also apparent in the basal layer. The staining was 
strongest in the cytoplasm of the epidermal keratinocytes. 
The expression of COP1 protein in normal human skin was also investigated by 
immunofluorescence labeling. In agreement with the immunohistochemistry, we found mild 
cytoplasmic staining in the basal layer of the epidermis and strong cytoplasmic staining was 
present in the granular layer. 
Next our aim was to study the effect of UVB irradiation on COP1 expression in human 
skin. Normal human skin was irradiated with 2 MED and skin biopsies were taken 24 and 48 
hs after irradiation. Both immunohistochemistry and immunofluorescence stainings indicated 
changes in COP1 expression in UVB-irradiated normal human skin. The COP1 expression 
was already decreased in both the stratum basale and the stratum granulosum 24 hs after the 
irradiation and was even lower 48 hs following the irradiation. These results suggest that the 
COP1 expression changes are part of the long-term stress response of human skin in response 
to UVB irradiation.  
 
 
4.5. The level of COP1 protein in differentiating keratinocytes 
The pattern of COP1 expression in the human epidermis prompted us to further 
analyze the changes in expression of COP1 in in vitro differentiating keratinocytes and to 
investigate the COP1-p53 relationship during differentiation. For the modeling of 
keratinocyte differentiation, we cultured keratinocytes in serum-free keratinocyte medium, 
with the addition of 1.7 mM calcium. To monitor the differentiation of keratinocytes, the 
expression of involucrin, a well-known differentiation marker, was investigated through 
western blotting, and we found an extremely high overexpression of the protein in parallel 
with the aging of the culture. p53 protein was expressed at a low level in the differentiating 
keratinocytes and did not exhibit change with time in the experimental period. In contrast, the 
initiation of differentiation resulted in a definitive decrease in COP1 protein in the 
keratinocyte culture; this decrease was already obvious 2 days after the induction of the 
differentiation. In parallel with this, we detected similar changes in COP1 expression in 
cultured normal human keratinocytes without calcium addition: the COP1 expression 
displayed a gradual decrease in cultured keratinocytes. 
 
 
5. DISCUSSION 
COP1, the Constitutive Photomorphogenic Protein 1, is well conserved across species: 
it is essential for normal photomorphogenesis in plants, and it has also been detected in 
mammalian cells. COP1 acts as a multifunctional ubiquitin ligase in plants and targets key 
transcription factors for proteasome-dependent degradation. Oravecz et al. reported that, in 
stark contrast to its negative regulatory function in the visible part of the spectrum, AtCOP1 
acts as a positive regulator of UVB-induced signaling in plant cells, and UVB irradiation 
promotes the accumulation of AtCOP1 in the nucleus. These data indicate that AtCOP1 is a 
multifunctional E3 ligase, and both its subcellular distribution and its substrate specificity are 
wavelength-specific. The striking degree of structural conservation of huCOP1 with its 
Arabidopsis counterpart suggested the possibility of a functional similarity too. Similarly to 
AtCOP1, MmCOP1 and huCOP1 are also present in the nucleus and the cytoplasm of cells.  
 
The initial characterization showed that MmCOP1 (rodent), like its plant counterpart, 
is indeed involved in ubiquitination and is itself a substrate of its own ubiquitination activity. 
The huCOP1 ubiquitin ligase has been found to promote ubiquitin-dependent p53 degradation 
directly by the 26S proteasome. This process is independent of Mdm2 or Pirh2, which are 
also known to interact with and negatively regulate p53. The expression of huCOP1 has been 
detected in many cell lines, but its role in human cells is still not well characterized. 
 
Our aim was therefore to investigate in detail the expression and function of huCOP1 
in keratinocytes, the cell type most exposed to UVB irradiation. Our investigations showed 
that COP1 protein is present in human keratinocytes and immortalized HaCaT keratinocytes. 
COP1 protein is predominantly expressed in the nucleus of keratinocytes under unstressed 
conditions, and milder positivity is detected in the cytoplasm. It was previously demonstrated 
by others that, in an unstressed condition, p53 also shows a predominantly nuclear 
localization, and it is monoubiquitinated by Mdm2. Following monoubiquitination, p53 may 
remain in the nucleus to be polyubiquitinated by Mdm2, Pirh2, COP1 or a complex of these 
proteins, or it may be exported to the cytoplasm. All these processes explain the high nuclear 
expression of COP1 protein. The nuclear export of p53 promotes its cytosolic accumulation 
where it is further polyubiquitinated by Mdm2, Pirh2, COP1 or a complex of these proteins 
and degradated in the cytosolic 26S proteasome. 
 
The comparison of the COP1 mRNA levels in various human tissues revealed that the 
epidermis expressed a significantly lower level of COP1 mRNA than the colon or gallbladder, 
but it was higher as compared with the breast tissue, where it was almost undetectable. A 
weak COP1 signal in normal breast tissue has already been described, whereas in breast 
adenocarcinoma the overexpression of the protein was detected. The same was demonstrated 
in ovarian adenocarcinomas, where the positive COP1 signal was present only within the 
malignant cells, and the stromal compartment or normal ovarian tissues were negative. This is 
concomitant mainly with a decrease in steady-state wild-type p53 protein levels or p53-
dependent transcription, indicating that one of the major roles of COP1 is to repress p53-
dependent tumor suppression. The fact that we detected COP1 in the epidermis affirmed our 
aim of investigating its physiological functions in normal skin. 
 
In order to elucidate the biological function of COP1 in the major constituent cell type 
of the epidermis, the keratinocytes, we investigated its expression in response to genotoxic 
stress such as UVB light. Although UVB light is the most prominent genotoxic stress for 
keratinocytes, its effect on COP1 expression has not yet been investigated in these cells. 
Previously, it was shown that COP1 protein expression is decreased following IR treatment in 
wild-type p53-expressing U2OS osteosarcoma cells and fibroblasts. It has also been 
demonstrated that a decreased abundance of COP1 protein can not be attributed to a decrease 
in COP1 mRNA level. Another previous investigation has shown that treatment with UV 
irradiation results in a COP1 protein decrease in NIH3T3 mouse fibroblast cells. In the 
present study, we found that the COP1 mRNA level exhibited a biphasic response to UVB. It 
was decreased early after UVB irradiation, and a slow increase was observed after 12 hs. In 
contrast with the biphasic mRNA profile, the COP1 protein level displayed a steady slow, but 
marked decrease. In a previous study, UVC stress induced an increase in COP1 protein level 
in both HeLa and U2OS cells, although the COP1 mRNA showed a biphasic response 
characterized by a downregulation at early timepoints followed by a subsequent upregulation. 
These observations indicate that UV irradiation differentially affects COP1 protein levels in 
human keratinocytes and cancer cells.  
 
Several data suggest that, besides its expression changes, the function of COP1 may 
also be altered by its intracellular movement. The first data on COP1 intracellular localization 
revealed that UVB induces the subcellular redistribution of AtCOP1. However, in 
Arabidopsis thaliana, UVB increased the accumulation of AtCOP1 in the nuclei and AtCOP1 
has been postulated to regulate UVB responses positively. This is in marked contrast with 
mammalian cells, in which the immunofluorescence staining of COP1 indicated intensive 
positivity, mainly in the nucleus, in the absence of UVB. A similar subcellular redistribution 
of COP1 protein was also detected: ionizing radiation results in the nuclear export of COP1 
protein in Flag-COP1-transfected H1299 cells, the primarily nuclear COP1 staining becoming 
cytosolic after IR. In line with the above findings, our results showed that UVB irradiation 
resulted in a similar decrease in COP1 protein both in the nuclei and in the cytoplasm, and a 
marked amount of the protein was centered in the perinuclear region of the cytoplasm. This 
means that in normal keratinocytes UVB irradiation caused not only a significant decrease in 
the COP1 protein level, but also a notable subcellular redistribution.  
 
COP1 is a negative regulator of p53, and the depletion of COP1 by siRNA therefore 
stabilizes p53: COP1 silencing resulted in a higher p53 protein level in unstressed U2OS 
cells. In agreement with this, in our experimental set-up we saw that the depletion of COP1 by 
siRNA in normal keratinocytes resulted in an increase in p53 steady-state levels in unstressed 
conditions, indicating that COP1 has a negative regulatory role on p53 in keratinocytes too. 
We investigated the COP1-p53 connection in UVB-induced keratinocytes and found that the 
UVB irradiation of COP1-silenced keratinocytes resulted in an enhanced accumulation of p53 
protein that was evident 24 h after the irradiation. COP1 silencing and UVB irradiation 
exerted an additive effect on p53 protein accumulation. This indicates that depletion of COP1 
stabilizes p53 protein in both unstressed cells and UVB-irradiated cells and that the lack of 
COP1 may sensitize keratinocytes to UVB-induced cell death. Taken together, these results 
suggest that COP1 has an important role in the UVB response and fine tuning of apoptotic 
processes of keratinocytes by regulating p53.  
 
We saw that huCOP1 contributes to the UV-induced stress response of keratinocytes. 
Next, we set out to investigate whether this molecule has any role in the regulation of 
keratinocyte differentiation and proliferation. We found that COP1 is highly expressed in 
normal human skin, in both the basal and the granular layers. This suggests that COP1 may 
have a role in the early steps of differentiation, in which the decision occurs as to whether the 
basal proliferating cell will enter the proliferation program. HuCOP1 is also expressed in the 
granular layer of the epidermis, in cells that are in the final stages of differentiation before cell 
death and cornification. The pleiotropic nature of huCOP1 and its role in complex regulatory 
functions could be revealed when huCOP1 and p53 expressions were studied in different 
layers of the normal epidermis upon UVB irradiation. p53 levels are low in the normal 
epidermis, and its induction results in the apoptosis of proliferating keratinocytes; as 
keratinocytes differentiate, they become insensitive to p53-induced apoptosis. It is well 
known that UVB light induces p53 in the proliferative compartment of the basal layer, 
resulting in protection from the tumorigenic effects of DNA damage; in our experiments we 
detected the opposite: decreases of the huCOP1 level in both the basal and the granular layer.  
 
Consistent with the huCOP1 staining in the epidermis, differentiating keratinocytes 
express COP1 in the proliferative stage. As keratinocytes lose their proliferation potential and 
begin to express differentiation markers such as involucrin, K1 and K10, the COP1 
expression undergoes a gradual decrease. This decrease was not associated with any changes 
in the level of p53; in fact, the p53 level did not show marked changes through differentiation. 
These in vitro data are in agreement with the immunohistochemical data that huCOP1 is 
decreased in the suprabasal layer as compared with the basal layer of keratinocytes. The 
gradual decrease of COP1 protein in differentiating keratinocytes indicates that indeed COP1 
is important through p53 regulation in the induction of keratinocytes apoptosis. The reason 
why fully differentiated, non-proliferative keratinocytes, which do not express p53, still 
contain COP1 is not clear. Further studies are needed to determine whether COP1 has other 
functions. 
Our in vitro and in vivo data suggest that huCOP1 has a role in the fine tuning of UVB 
response in keratinocytes via regulation of the p53 function. The high level of huCOP1 in the 
basal layer of the epidermis, a UV-sensitive proliferating layer, is also an important 
observation in our experiments, suggesting that huCOP1 has an important role and may 
function as an oncogene which promotes tumorigenesis in p53-expressing cells, and that 
interventions targeting huCOP1 could well provide new opportunities in cancer therapy.  
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